« Back
Home /
Emapalumab (anti-IFNγ)

Emapalumab (anti-IFNγ)

Item no.	A2041-25mg
Manufacturer	Selleckchem
CASRN	1709815-23-5
Amount	1 mg x 25
Quantity options	1 mg 1 mg x 25 1 mg x 5
Category	Antibodies Primary Antibodies
Type	Antibody
Specific against	other
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	Gamifant
Available
Storage Conditions	Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles.
Information	Emapalumab (anti-IFNγ), a monoclonal antibody directed against IFNγ, is the first global approval for the treatment of pediatric and adult patients with primary hemophagocytic lymphohistiocytosis (HLH) with refractory.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

A2041-25mg-datasheet.pdf

A2041-25mg-safety-datasheet.pdf